NCT01771354View on ClinicalTrials.gov

Training Study to Characterise Biomarkers to the Engerix B Vaccine

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Healthy
Interventions
BIOLOGICAL

Engerix B Vaccine

BIOLOGICAL

Placebo

Trial Locations (1)

GU2 7XP

University of Surrey, Surrey CRC, Guildford

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

Innovative Medicines Initiative

OTHER

collaborator

GlaxoSmithKline

INDUSTRY

lead

University of Surrey

OTHER

NCT01771354 - Training Study to Characterise Biomarkers to the Engerix B Vaccine | Biotech Hunter | Biotech Hunter